Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: titanium dioxide; macrogol 6000; hypromellose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; glycerol; povidone - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally, ardix indapamide sr is used as the initial agent in multiple drug regimes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: magnesium stearate; povidone; hypromellose; titanium dioxide; glycerol; macrogol 6000; colloidal anhydrous silica; lactose monohydrate - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally,tenaxil sr is used as the initial agent in multiple drug regimes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; hydrophobic colloidal silica anhydrous - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindo be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindo has not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hydrophobic colloidal silica anhydrous; lactose monohydrate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindo be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindo has not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 4 mg; indapamide hemihydrate, quantity: 1.25 mg - tablet, uncoated - excipient ingredients: hydrophobic colloidal silica anhydrous; magnesium stearate; microcrystalline cellulose; lactose monohydrate - treatment of hypertension. treatment should not be initiated with this combination.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - strontium ranelate -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 4 mg; indapamide hemihydrate, quantity: 1.25 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hydrophobic colloidal silica anhydrous; lactose monohydrate - treatment of hypertension. treatment should not be initiated with this combination.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 4 mg; indapamide hemihydrate, quantity: 1.25 mg - tablet, uncoated - excipient ingredients: hydrophobic colloidal silica anhydrous; lactose monohydrate; magnesium stearate; microcrystalline cellulose - treatment of hypertension. treatment should not be initiated with this combination.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: magnesium stearate; hydrophobic colloidal silica anhydrous; microcrystalline cellulose; lactose monohydrate - the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that idaprex be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of idaprex has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; hydrophobic colloidal silica anhydrous; magnesium stearate; lactose monohydrate - the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that idaprex be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of idaprex has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.